Complexity of polypharmacological treatment in a case of resistant schizophrenia
First meeting with the patient
"Thank you for coming here, doctor," Angela's father says. In the middle of the smelly living room, he tells you about Angela's symptoms.
"You should probably know that my wife, Angela's mother, suffers from severe depression. She's been on medication for about 15 years," he begins their story.
You ask about Angela's past. According to her father, she developed as a healthy child.
"It's true that in high school she started to be rather reclusive, she had no one close to her. The only person she always interacted with and maintained a very close relationship with was our second daughter, Angela's sister," explains the father.
Angela earned a diploma in accounting and enrolled in law school. But she didn't last long at university.
"She said it didn't do her any good to attend such crowded places," recalls her father.
From that time, she became more and more isolated and worried. She lost interest in many activities and friendships.
OK, I got it.
This virtual patient case was created on the basis of clinical practice outside the EU and may, therefore, include an off-label practice.
I agree with playing a virtual patient case authored outside the EU. I will not draw any consequences from this case for my own or any other practice, as this case may contain unapproved use of an approved drug.